nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—CYP19A1—gestational diabetes	0.451	1	CbGaD
Tamoxifen—ABCB11—Glyburide—gestational diabetes	0.15	0.375	CbGbCtD
Tamoxifen—ABCC2—Glyburide—gestational diabetes	0.079	0.197	CbGbCtD
Tamoxifen—ABCG2—Glyburide—gestational diabetes	0.0714	0.178	CbGbCtD
Tamoxifen—CYP2C19—Glyburide—gestational diabetes	0.0319	0.0797	CbGbCtD
Tamoxifen—CYP2C9—Glyburide—gestational diabetes	0.0265	0.0663	CbGbCtD
Tamoxifen—ABCB1—Glyburide—gestational diabetes	0.0257	0.0643	CbGbCtD
Tamoxifen—CYP3A4—Glyburide—gestational diabetes	0.0154	0.0385	CbGbCtD
Tamoxifen—Porphyria cutanea tarda—Glyburide—gestational diabetes	0.0124	0.198	CcSEcCtD
Tamoxifen—Porphyria non-acute—Glyburide—gestational diabetes	0.0116	0.186	CcSEcCtD
Tamoxifen—Myelosuppression—Glyburide—gestational diabetes	0.00384	0.0612	CcSEcCtD
Tamoxifen—Blindness—Glyburide—gestational diabetes	0.00325	0.0518	CcSEcCtD
Tamoxifen—Cholestasis—Glyburide—gestational diabetes	0.00237	0.0378	CcSEcCtD
Tamoxifen—EBPL—adipose tissue—gestational diabetes	0.00194	0.0457	CbGeAlD
Tamoxifen—EBP—uterus—gestational diabetes	0.0019	0.0448	CbGeAlD
Tamoxifen—Vasculitis—Glyburide—gestational diabetes	0.00184	0.0294	CcSEcCtD
Tamoxifen—DHCR7—islet of Langerhans—gestational diabetes	0.00172	0.0405	CbGeAlD
Tamoxifen—ESRRA—islet of Langerhans—gestational diabetes	0.00169	0.0399	CbGeAlD
Tamoxifen—SULT1A1—adipose tissue—gestational diabetes	0.00154	0.0363	CbGeAlD
Tamoxifen—Hepatic function abnormal—Glyburide—gestational diabetes	0.0015	0.0238	CcSEcCtD
Tamoxifen—EBPL—head—gestational diabetes	0.00149	0.0351	CbGeAlD
Tamoxifen—Hepatic failure—Glyburide—gestational diabetes	0.00145	0.0232	CcSEcCtD
Tamoxifen—Visual disturbance—Glyburide—gestational diabetes	0.00138	0.022	CcSEcCtD
Tamoxifen—Dermatitis bullous—Glyburide—gestational diabetes	0.00137	0.0218	CcSEcCtD
Tamoxifen—Arthritis—Glyburide—gestational diabetes	0.00134	0.0214	CcSEcCtD
Tamoxifen—SULT1A1—vagina—gestational diabetes	0.00128	0.0302	CbGeAlD
Tamoxifen—SULT1A1—head—gestational diabetes	0.00119	0.0279	CbGeAlD
Tamoxifen—Diethylstilbestrol—CYP19A1—gestational diabetes	0.00116	0.394	CrCbGaD
Tamoxifen—Pancreatitis—Glyburide—gestational diabetes	0.00111	0.0177	CcSEcCtD
Tamoxifen—ESRRA—uterus—gestational diabetes	0.0011	0.026	CbGeAlD
Tamoxifen—DHCR7—adipose tissue—gestational diabetes	0.0011	0.0258	CbGeAlD
Tamoxifen—FMO1—adipose tissue—gestational diabetes	0.0011	0.0258	CbGeAlD
Tamoxifen—ESRRA—adipose tissue—gestational diabetes	0.00108	0.0254	CbGeAlD
Tamoxifen—Pancytopenia—Glyburide—gestational diabetes	0.00107	0.0171	CcSEcCtD
Tamoxifen—FMO3—adipose tissue—gestational diabetes	0.000949	0.0223	CbGeAlD
Tamoxifen—DHCR7—vagina—gestational diabetes	0.000913	0.0215	CbGeAlD
Tamoxifen—FMO1—vagina—gestational diabetes	0.000913	0.0215	CbGeAlD
Tamoxifen—Hepatitis—Glyburide—gestational diabetes	0.000904	0.0144	CcSEcCtD
Tamoxifen—ESRRA—vagina—gestational diabetes	0.000898	0.0211	CbGeAlD
Tamoxifen—Visual impairment—Glyburide—gestational diabetes	0.000871	0.0139	CcSEcCtD
Tamoxifen—DHCR7—head—gestational diabetes	0.000843	0.0198	CbGeAlD
Tamoxifen—FMO1—head—gestational diabetes	0.000843	0.0198	CbGeAlD
Tamoxifen—ESRRA—head—gestational diabetes	0.00083	0.0195	CbGeAlD
Tamoxifen—Alopecia—Glyburide—gestational diabetes	0.000799	0.0127	CcSEcCtD
Tamoxifen—Clomifene—CYP19A1—gestational diabetes	0.000792	0.27	CrCbGaD
Tamoxifen—FMO3—vagina—gestational diabetes	0.000789	0.0186	CbGeAlD
Tamoxifen—SIGMAR1—islet of Langerhans—gestational diabetes	0.000788	0.0185	CbGeAlD
Tamoxifen—Erythema—Glyburide—gestational diabetes	0.000787	0.0125	CcSEcCtD
Tamoxifen—CES1—adipose tissue—gestational diabetes	0.000749	0.0176	CbGeAlD
Tamoxifen—FMO3—head—gestational diabetes	0.000729	0.0172	CbGeAlD
Tamoxifen—Anaemia—Glyburide—gestational diabetes	0.000727	0.0116	CcSEcCtD
Tamoxifen—Angioedema—Glyburide—gestational diabetes	0.000719	0.0115	CcSEcCtD
Tamoxifen—Leukopenia—Glyburide—gestational diabetes	0.000705	0.0112	CcSEcCtD
Tamoxifen—ESR1—embryo—gestational diabetes	0.000674	0.0159	CbGeAlD
Tamoxifen—Myalgia—Glyburide—gestational diabetes	0.00067	0.0107	CcSEcCtD
Tamoxifen—Arthralgia—Glyburide—gestational diabetes	0.00067	0.0107	CcSEcCtD
Tamoxifen—ESR2—uterus—gestational diabetes	0.000663	0.0156	CbGeAlD
Tamoxifen—CYP2A6—adipose tissue—gestational diabetes	0.000652	0.0153	CbGeAlD
Tamoxifen—Oedema—Glyburide—gestational diabetes	0.000642	0.0102	CcSEcCtD
Tamoxifen—Thrombocytopenia—Glyburide—gestational diabetes	0.000629	0.01	CcSEcCtD
Tamoxifen—Hyperhidrosis—Glyburide—gestational diabetes	0.000621	0.0099	CcSEcCtD
Tamoxifen—Levomethadyl Acetate—CYP19A1—gestational diabetes	0.000619	0.211	CrCbGaD
Tamoxifen—Anorexia—Glyburide—gestational diabetes	0.000612	0.00976	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000585	0.00933	CcSEcCtD
Tamoxifen—Paraesthesia—Glyburide—gestational diabetes	0.000577	0.0092	CcSEcCtD
Tamoxifen—CES1—head—gestational diabetes	0.000575	0.0135	CbGeAlD
Tamoxifen—Dyspnoea—Glyburide—gestational diabetes	0.000573	0.00913	CcSEcCtD
Tamoxifen—Dyspepsia—Glyburide—gestational diabetes	0.000565	0.00901	CcSEcCtD
Tamoxifen—Decreased appetite—Glyburide—gestational diabetes	0.000558	0.0089	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000555	0.00884	CcSEcCtD
Tamoxifen—CYP2A6—vagina—gestational diabetes	0.000542	0.0128	CbGeAlD
Tamoxifen—ESR2—vagina—gestational diabetes	0.000539	0.0127	CbGeAlD
Tamoxifen—Gastrointestinal pain—Glyburide—gestational diabetes	0.000525	0.00837	CcSEcCtD
Tamoxifen—CYP19A1—uterus—gestational diabetes	0.000523	0.0123	CbGeAlD
Tamoxifen—CYP3A5—islet of Langerhans—gestational diabetes	0.000518	0.0122	CbGeAlD
Tamoxifen—SIGMAR1—uterus—gestational diabetes	0.000514	0.0121	CbGeAlD
Tamoxifen—CYP19A1—adipose tissue—gestational diabetes	0.000511	0.012	CbGeAlD
Tamoxifen—Urticaria—Glyburide—gestational diabetes	0.00051	0.00814	CcSEcCtD
Tamoxifen—Abdominal pain—Glyburide—gestational diabetes	0.000508	0.0081	CcSEcCtD
Tamoxifen—SIGMAR1—adipose tissue—gestational diabetes	0.000503	0.0118	CbGeAlD
Tamoxifen—ESR2—head—gestational diabetes	0.000498	0.0117	CbGeAlD
Tamoxifen—CYP1B1—uterus—gestational diabetes	0.000489	0.0115	CbGeAlD
Tamoxifen—CYP1B1—adipose tissue—gestational diabetes	0.000478	0.0112	CbGeAlD
Tamoxifen—Hypersensitivity—Glyburide—gestational diabetes	0.000473	0.00755	CcSEcCtD
Tamoxifen—Asthenia—Glyburide—gestational diabetes	0.000461	0.00735	CcSEcCtD
Tamoxifen—Pruritus—Glyburide—gestational diabetes	0.000454	0.00725	CcSEcCtD
Tamoxifen—ESR1—uterus—gestational diabetes	0.000454	0.0107	CbGeAlD
Tamoxifen—ESR1—adipose tissue—gestational diabetes	0.000444	0.0105	CbGeAlD
Tamoxifen—Diarrhoea—Glyburide—gestational diabetes	0.00044	0.00701	CcSEcCtD
Tamoxifen—SIGMAR1—vagina—gestational diabetes	0.000418	0.00983	CbGeAlD
Tamoxifen—Vomiting—Glyburide—gestational diabetes	0.000408	0.00651	CcSEcCtD
Tamoxifen—Rash—Glyburide—gestational diabetes	0.000405	0.00646	CcSEcCtD
Tamoxifen—Dermatitis—Glyburide—gestational diabetes	0.000405	0.00645	CcSEcCtD
Tamoxifen—Headache—Glyburide—gestational diabetes	0.000402	0.00642	CcSEcCtD
Tamoxifen—CYP19A1—head—gestational diabetes	0.000392	0.00924	CbGeAlD
Tamoxifen—Nausea—Glyburide—gestational diabetes	0.000382	0.00608	CcSEcCtD
Tamoxifen—ESR1—vagina—gestational diabetes	0.000369	0.00869	CbGeAlD
Tamoxifen—CYP1B1—head—gestational diabetes	0.000367	0.00864	CbGeAlD
Tamoxifen—ABCG2—uterus—gestational diabetes	0.000364	0.00856	CbGeAlD
Tamoxifen—Methadone—CYP19A1—gestational diabetes	0.000363	0.124	CrCbGaD
Tamoxifen—ABCG2—adipose tissue—gestational diabetes	0.000356	0.00838	CbGeAlD
Tamoxifen—CYP2C19—vagina—gestational diabetes	0.000349	0.00821	CbGeAlD
Tamoxifen—CYP1A1—uterus—gestational diabetes	0.000345	0.00813	CbGeAlD
Tamoxifen—ESR1—head—gestational diabetes	0.000341	0.00803	CbGeAlD
Tamoxifen—CYP1A1—adipose tissue—gestational diabetes	0.000338	0.00795	CbGeAlD
Tamoxifen—CYP3A5—adipose tissue—gestational diabetes	0.00033	0.00778	CbGeAlD
Tamoxifen—CYP2C8—vagina—gestational diabetes	0.000304	0.00716	CbGeAlD
Tamoxifen—ABCG2—vagina—gestational diabetes	0.000296	0.00696	CbGeAlD
Tamoxifen—CYP1A1—vagina—gestational diabetes	0.000281	0.00661	CbGeAlD
Tamoxifen—ABCB1—islet of Langerhans—gestational diabetes	0.000275	0.00648	CbGeAlD
Tamoxifen—CYP3A5—vagina—gestational diabetes	0.000275	0.00646	CbGeAlD
Tamoxifen—CYP2B6—vagina—gestational diabetes	0.000273	0.00642	CbGeAlD
Tamoxifen—ABCB1—embryo—gestational diabetes	0.000266	0.00626	CbGeAlD
Tamoxifen—CYP1A1—head—gestational diabetes	0.000259	0.00611	CbGeAlD
Tamoxifen—CYP2B6—head—gestational diabetes	0.000252	0.00593	CbGeAlD
Tamoxifen—CYP2E1—head—gestational diabetes	0.000237	0.00557	CbGeAlD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000217	0.00529	CbGpPWpGaD
Tamoxifen—CYP1A2—Phase II conjugation—GGCT—gestational diabetes	0.000216	0.00527	CbGpPWpGaD
Tamoxifen—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000215	0.00524	CbGpPWpGaD
Tamoxifen—CYP2B6—Biological oxidations—GGCT—gestational diabetes	0.000215	0.00523	CbGpPWpGaD
Tamoxifen—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000212	0.00517	CbGpPWpGaD
Tamoxifen—CYP1B1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000211	0.00514	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—GGCT—gestational diabetes	0.000211	0.00513	CbGpPWpGaD
Tamoxifen—CYP2E1—Biological oxidations—GGCT—gestational diabetes	0.00021	0.00513	CbGpPWpGaD
Tamoxifen—CYP2E1—Tryptophan metabolism—CYP19A1—gestational diabetes	0.00021	0.00512	CbGpPWpGaD
Tamoxifen—CYP3A5—Biological oxidations—GGCT—gestational diabetes	0.00021	0.00511	CbGpPWpGaD
Tamoxifen—UGT1A4—Biological oxidations—CYP19A1—gestational diabetes	0.000209	0.0051	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—GGCT—gestational diabetes	0.000207	0.00503	CbGpPWpGaD
Tamoxifen—UGT1A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000206	0.00503	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—GGCT—gestational diabetes	0.0002	0.00486	CbGpPWpGaD
Tamoxifen—CYP1A1—Biological oxidations—GGCT—gestational diabetes	0.000198	0.00483	CbGpPWpGaD
Tamoxifen—CYP1A1—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000198	0.00483	CbGpPWpGaD
Tamoxifen—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000195	0.00474	CbGpPWpGaD
Tamoxifen—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00019	0.00464	CbGpPWpGaD
Tamoxifen—CYP2D6—head—gestational diabetes	0.000187	0.00441	CbGeAlD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—AR—gestational diabetes	0.000185	0.00451	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000185	0.0045	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—GLS2—gestational diabetes	0.000184	0.00448	CbGpPWpGaD
Tamoxifen—CYP2C8—Biological oxidations—GGCT—gestational diabetes	0.000182	0.00443	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—GLS2—gestational diabetes	0.000181	0.0044	CbGpPWpGaD
Tamoxifen—ABCB1—uterus—gestational diabetes	0.000179	0.00422	CbGeAlD
Tamoxifen—ABCB1—adipose tissue—gestational diabetes	0.000175	0.00413	CbGeAlD
Tamoxifen—EBP—Metabolism—GLS2—gestational diabetes	0.000175	0.00425	CbGpPWpGaD
Tamoxifen—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000174	0.00425	CbGpPWpGaD
Tamoxifen—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000174	0.00423	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—GGCT—gestational diabetes	0.000172	0.00418	CbGpPWpGaD
Tamoxifen—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000171	0.00417	CbGpPWpGaD
Tamoxifen—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00017	0.00414	CbGpPWpGaD
Tamoxifen—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00017	0.00413	CbGpPWpGaD
Tamoxifen—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000168	0.00409	CbGpPWpGaD
Tamoxifen—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000167	0.00408	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000165	0.00401	CbGpPWpGaD
Tamoxifen—CYP2C19—Biological oxidations—GGCT—gestational diabetes	0.000162	0.00395	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000162	0.00395	CbGpPWpGaD
Tamoxifen—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00016	0.0039	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—GGCT—gestational diabetes	0.00016	0.00389	CbGpPWpGaD
Tamoxifen—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000158	0.00385	CbGpPWpGaD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000156	0.0038	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000154	0.00374	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—GLS2—gestational diabetes	0.00015	0.00365	CbGpPWpGaD
Tamoxifen—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.000149	0.00364	CbGpPWpGaD
Tamoxifen—CYP2C9—Biological oxidations—GGCT—gestational diabetes	0.000148	0.00361	CbGpPWpGaD
Tamoxifen—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000147	0.00358	CbGpPWpGaD
Tamoxifen—ABCB1—vagina—gestational diabetes	0.000146	0.00343	CbGeAlD
Tamoxifen—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000145	0.00353	CbGpPWpGaD
Tamoxifen—ESRRA—Generic Transcription Pathway—AR—gestational diabetes	0.000144	0.00352	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—LEP—gestational diabetes	0.000142	0.00345	CbGpPWpGaD
Tamoxifen—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000141	0.00343	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—GLS2—gestational diabetes	0.00014	0.0034	CbGpPWpGaD
Tamoxifen—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000138	0.00336	CbGpPWpGaD
Tamoxifen—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000138	0.00335	CbGpPWpGaD
Tamoxifen—ABCB1—head—gestational diabetes	0.000135	0.00317	CbGeAlD
Tamoxifen—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000131	0.0032	CbGpPWpGaD
Tamoxifen—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00013	0.00317	CbGpPWpGaD
Tamoxifen—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000129	0.00315	CbGpPWpGaD
Tamoxifen—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.000127	0.00308	CbGpPWpGaD
Tamoxifen—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000126	0.00308	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000126	0.00306	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000125	0.00304	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GGCT—gestational diabetes	0.000123	0.00299	CbGpPWpGaD
Tamoxifen—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000121	0.00294	CbGpPWpGaD
Tamoxifen—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00012	0.00291	CbGpPWpGaD
Tamoxifen—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000119	0.0029	CbGpPWpGaD
Tamoxifen—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000119	0.0029	CbGpPWpGaD
Tamoxifen—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000118	0.00288	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000116	0.00282	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000113	0.00274	CbGpPWpGaD
Tamoxifen—CYP1B1—Biological oxidations—CYP19A1—gestational diabetes	0.000112	0.00273	CbGpPWpGaD
Tamoxifen—CYP1B1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000111	0.00269	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GLS2—gestational diabetes	0.000107	0.00261	CbGpPWpGaD
Tamoxifen—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000106	0.00259	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000104	0.00254	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000104	0.00254	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GGCT—gestational diabetes	0.000103	0.00251	CbGpPWpGaD
Tamoxifen—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000102	0.00249	CbGpPWpGaD
Tamoxifen—CYP3A7—Biological oxidations—CYP19A1—gestational diabetes	0.000101	0.00246	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000101	0.00246	CbGpPWpGaD
Tamoxifen—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000101	0.00246	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—NAMPT—gestational diabetes	0.000101	0.00246	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—GCK—gestational diabetes	0.0001	0.00244	CbGpPWpGaD
Tamoxifen—CYP3A7—Metapathway biotransformation—CYP19A1—gestational diabetes	9.97e-05	0.00243	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—NAMPT—gestational diabetes	9.9e-05	0.00241	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—GCK—gestational diabetes	9.84e-05	0.0024	CbGpPWpGaD
Tamoxifen—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	9.78e-05	0.00238	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—GGCT—gestational diabetes	9.76e-05	0.00238	CbGpPWpGaD
Tamoxifen—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	9.76e-05	0.00238	CbGpPWpGaD
Tamoxifen—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	9.7e-05	0.00236	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	9.69e-05	0.00236	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—NAMPT—gestational diabetes	9.56e-05	0.00233	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—GCK—gestational diabetes	9.5e-05	0.00231	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	9.32e-05	0.00227	CbGpPWpGaD
Tamoxifen—CYP2A6—Biological oxidations—CYP19A1—gestational diabetes	9.27e-05	0.00226	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—AR—gestational diabetes	9.18e-05	0.00224	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GLS2—gestational diabetes	8.99e-05	0.00219	CbGpPWpGaD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—TNF—gestational diabetes	8.74e-05	0.00213	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	8.3e-05	0.00202	CbGpPWpGaD
Tamoxifen—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	8.29e-05	0.00202	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—NAMPT—gestational diabetes	8.22e-05	0.002	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—GCK—gestational diabetes	8.17e-05	0.00199	CbGpPWpGaD
Tamoxifen—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	7.89e-05	0.00192	CbGpPWpGaD
Tamoxifen—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	7.79e-05	0.0019	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—NAMPT—gestational diabetes	7.64e-05	0.00186	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—GCK—gestational diabetes	7.6e-05	0.00185	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GGCT—gestational diabetes	7.58e-05	0.00185	CbGpPWpGaD
Tamoxifen—CYP2B6—Biological oxidations—CYP19A1—gestational diabetes	7.48e-05	0.00182	CbGpPWpGaD
Tamoxifen—CYP2B6—Metapathway biotransformation—CYP19A1—gestational diabetes	7.37e-05	0.0018	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—CYP19A1—gestational diabetes	7.33e-05	0.00178	CbGpPWpGaD
Tamoxifen—CYP2E1—Biological oxidations—CYP19A1—gestational diabetes	7.32e-05	0.00178	CbGpPWpGaD
Tamoxifen—CYP3A5—Biological oxidations—CYP19A1—gestational diabetes	7.31e-05	0.00178	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—TNF—gestational diabetes	7.23e-05	0.00176	CbGpPWpGaD
Tamoxifen—CYP2E1—Metapathway biotransformation—CYP19A1—gestational diabetes	7.22e-05	0.00176	CbGpPWpGaD
Tamoxifen—CYP3A5—Metapathway biotransformation—CYP19A1—gestational diabetes	7.21e-05	0.00176	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—CYP19A1—gestational diabetes	7.19e-05	0.00175	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—AR—gestational diabetes	6.95e-05	0.00169	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—CYP19A1—gestational diabetes	6.95e-05	0.00169	CbGpPWpGaD
Tamoxifen—CYP1A1—Biological oxidations—CYP19A1—gestational diabetes	6.9e-05	0.00168	CbGpPWpGaD
Tamoxifen—CYP1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	6.81e-05	0.00166	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GLS2—gestational diabetes	6.63e-05	0.00161	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	6.42e-05	0.00156	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	6.42e-05	0.00156	CbGpPWpGaD
Tamoxifen—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	6.4e-05	0.00156	CbGpPWpGaD
Tamoxifen—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	6.33e-05	0.00154	CbGpPWpGaD
Tamoxifen—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	6.24e-05	0.00152	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	6.15e-05	0.0015	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—FGF2—gestational diabetes	6.11e-05	0.00149	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—CYP19A1—gestational diabetes	5.97e-05	0.00146	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.92e-05	0.00144	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—NAMPT—gestational diabetes	5.88e-05	0.00143	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—GCK—gestational diabetes	5.86e-05	0.00143	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GCK—gestational diabetes	5.84e-05	0.00142	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GGCT—gestational diabetes	5.72e-05	0.00139	CbGpPWpGaD
Tamoxifen—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	5.65e-05	0.00138	CbGpPWpGaD
Tamoxifen—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	5.57e-05	0.00136	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—CYP19A1—gestational diabetes	5.55e-05	0.00135	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GGCT—gestational diabetes	5.51e-05	0.00134	CbGpPWpGaD
Tamoxifen—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	5.2e-05	0.00127	CbGpPWpGaD
Tamoxifen—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	5.15e-05	0.00125	CbGpPWpGaD
Tamoxifen—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	5.12e-05	0.00125	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	5.09e-05	0.00124	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	5.09e-05	0.00124	CbGpPWpGaD
Tamoxifen—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	5.08e-05	0.00124	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GGCT—gestational diabetes	5.01e-05	0.00122	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GLS2—gestational diabetes	5e-05	0.00122	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GGCT—gestational diabetes	4.97e-05	0.00121	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	4.93e-05	0.0012	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—NAMPT—gestational diabetes	4.93e-05	0.0012	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GCK—gestational diabetes	4.9e-05	0.00119	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GLS2—gestational diabetes	4.82e-05	0.00117	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—AR—gestational diabetes	4.63e-05	0.00113	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GGCT—gestational diabetes	4.55e-05	0.00111	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—AR—gestational diabetes	4.42e-05	0.00108	CbGpPWpGaD
Tamoxifen—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	4.4e-05	0.00107	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GLS2—gestational diabetes	4.38e-05	0.00107	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GLS2—gestational diabetes	4.34e-05	0.00106	CbGpPWpGaD
Tamoxifen—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	4.34e-05	0.00106	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.3e-05	0.00105	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—CYP19A1—gestational diabetes	4.27e-05	0.00104	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	4.09e-05	0.000997	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	4.09e-05	0.000997	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GLS2—gestational diabetes	3.98e-05	0.000969	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GGCT—gestational diabetes	3.67e-05	0.000895	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—NAMPT—gestational diabetes	3.63e-05	0.000884	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GCK—gestational diabetes	3.61e-05	0.000879	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GGCT—gestational diabetes	3.6e-05	0.000876	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GGCT—gestational diabetes	3.59e-05	0.000875	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—CYP19A1—gestational diabetes	3.58e-05	0.000872	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	3.4e-05	0.000827	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GGCT—gestational diabetes	3.39e-05	0.000826	CbGpPWpGaD
Tamoxifen—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	3.35e-05	0.000816	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—TNF—gestational diabetes	3.33e-05	0.00081	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GLS2—gestational diabetes	3.21e-05	0.000782	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GLS2—gestational diabetes	3.15e-05	0.000766	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GLS2—gestational diabetes	3.14e-05	0.000765	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GGCT—gestational diabetes	3.11e-05	0.000758	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	3.1e-05	0.000755	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—LEPR—gestational diabetes	2.97e-05	0.000723	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GLS2—gestational diabetes	2.97e-05	0.000722	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GGCT—gestational diabetes	2.78e-05	0.000676	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	2.75e-05	0.000671	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—NAMPT—gestational diabetes	2.74e-05	0.000667	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GCK—gestational diabetes	2.72e-05	0.000663	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GLS2—gestational diabetes	2.72e-05	0.000662	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GGCT—gestational diabetes	2.71e-05	0.00066	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	2.69e-05	0.000656	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.65e-05	0.000646	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—NAMPT—gestational diabetes	2.64e-05	0.000643	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CYP19A1—gestational diabetes	2.64e-05	0.000643	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GCK—gestational diabetes	2.62e-05	0.000639	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GGCT—gestational diabetes	2.55e-05	0.000622	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GGCT—gestational diabetes	2.53e-05	0.000617	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.43e-05	0.000592	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GLS2—gestational diabetes	2.43e-05	0.000591	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—NAMPT—gestational diabetes	2.4e-05	0.000585	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GCK—gestational diabetes	2.39e-05	0.000581	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—NAMPT—gestational diabetes	2.38e-05	0.00058	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GLS2—gestational diabetes	2.37e-05	0.000577	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GCK—gestational diabetes	2.36e-05	0.000576	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MTNR1B—gestational diabetes	2.35e-05	0.000572	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RBP4—gestational diabetes	2.29e-05	0.000557	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GLS2—gestational diabetes	2.23e-05	0.000544	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AR—gestational diabetes	2.23e-05	0.000543	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GLS2—gestational diabetes	2.21e-05	0.000539	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—NAMPT—gestational diabetes	2.18e-05	0.000531	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.17e-05	0.000528	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GCK—gestational diabetes	2.17e-05	0.000528	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GGCT—gestational diabetes	2.16e-05	0.000527	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	1.98e-05	0.000482	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CYP19A1—gestational diabetes	1.92e-05	0.000467	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GLS2—gestational diabetes	1.89e-05	0.000461	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NAMPT—gestational diabetes	1.76e-05	0.000429	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GCK—gestational diabetes	1.75e-05	0.000426	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CYP19A1—gestational diabetes	1.74e-05	0.000425	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CYP19A1—gestational diabetes	1.73e-05	0.000421	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NAMPT—gestational diabetes	1.72e-05	0.00042	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NAMPT—gestational diabetes	1.72e-05	0.000419	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GCK—gestational diabetes	1.71e-05	0.000417	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GCK—gestational diabetes	1.71e-05	0.000416	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	1.69e-05	0.000412	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GGCT—gestational diabetes	1.67e-05	0.000407	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	1.64e-05	0.0004	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NAMPT—gestational diabetes	1.62e-05	0.000396	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GCK—gestational diabetes	1.61e-05	0.000393	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CYP19A1—gestational diabetes	1.58e-05	0.000386	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NAMPT—gestational diabetes	1.49e-05	0.000363	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GCK—gestational diabetes	1.48e-05	0.000361	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GLS2—gestational diabetes	1.46e-05	0.000355	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NAMPT—gestational diabetes	1.33e-05	0.000324	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GCK—gestational diabetes	1.32e-05	0.000322	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NAMPT—gestational diabetes	1.3e-05	0.000316	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GCK—gestational diabetes	1.29e-05	0.000314	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CYP19A1—gestational diabetes	1.28e-05	0.000311	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CYP19A1—gestational diabetes	1.25e-05	0.000305	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CYP19A1—gestational diabetes	1.25e-05	0.000304	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NAMPT—gestational diabetes	1.22e-05	0.000298	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GCK—gestational diabetes	1.22e-05	0.000296	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NAMPT—gestational diabetes	1.21e-05	0.000295	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GCK—gestational diabetes	1.2e-05	0.000293	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CYP19A1—gestational diabetes	1.18e-05	0.000288	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP19A1—gestational diabetes	1.08e-05	0.000264	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—LEP—gestational diabetes	1.04e-05	0.000254	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NAMPT—gestational diabetes	1.04e-05	0.000252	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GCK—gestational diabetes	1.03e-05	0.000251	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP19A1—gestational diabetes	9.66e-06	0.000235	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP19A1—gestational diabetes	9.43e-06	0.00023	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP19A1—gestational diabetes	8.89e-06	0.000216	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP19A1—gestational diabetes	8.81e-06	0.000215	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NAMPT—gestational diabetes	8e-06	0.000195	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GCK—gestational diabetes	7.95e-06	0.000194	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGF2—gestational diabetes	7.92e-06	0.000193	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP19A1—gestational diabetes	7.53e-06	0.000183	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP19A1—gestational diabetes	5.81e-06	0.000142	CbGpPWpGaD
